During Friday’s Current trade, Shares of Vanda Pharmaceuticals Inc.(NASDAQ:VNDA), lost -0.35% to $14.35.
Vanda Pharmaceuticals Inc. (Vanda) (VNDA) declared that the U.S. Food and Drug Administration (FDA) has accepted for review Vanda’s filing of a supplemental New Drug Application (sNDA) for Fanapt® seeking approval as a maintenance treatment of schizophrenia in adults.
Vanda is seeking approval based on the results of the REPRIEVE clinical study, which evaluated the long-term maintenance of efficacy and safety of Fanapt®.
The FDA has set a user fee aim date under the Prescription Drug User Fee Act of May 27, 2016, which is the target date for the FDA to complete its review of the sNDA.
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders.
Shares of DaVita HealthCare Partners Inc(NYSE:DVA), declined -0.25% to $75.58, during its current trading session.
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders.
The ride starts on Sept. 27 with cyclists pedaling through the Piedmont Region surrounded by lush pine forests and rural farmland from Sanford to Pinehurst, North Carolina.
Sept. 27 – Participants will ride 64 miles on a loop through a mix of forest and farmland in Sanford, North Carolina.
Sept. 28 – Following a portion of the Tour de Moore cycling route, this day features two options on a route from Sanford to Pinehurst, North Carolina. Riders can choose a 69-mile route or a 101-mile route.
Sept. 29 – Riders will complete a 65-mile loop in southwest Pinehurst on the final day of the event.
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals.
Dot Hill Systems Corp.(NASDAQ:HILL), during its Friday’s current trading session decreased -0.05% to $9.73.
Dot Hill Systems Corp. (HILL), the real-time hybrid storage company, declared that it has been awarded a patent that provides more efficient administration of read-cache operations. The patented technology is used by the storage controller to intelligently optimize cache memory, resulting in lower than average data read times contrast to traditional storage controllers. The technology is an integral component of RealStor(TM), Dot Hill’s real-time storage operating system, and is now accessible in Dot Hill’s AssuredSAN(R) 3004, 4004 and 6004 hybrid storage arrays.
Dot Hill’s AssuredSAN arrays are built with robust active-active high availability controllers that deliver performance, reliability and resilience for demanding storage applications in server-centric applications in data centers and purpose-built vertical market applications. This patented technology optimizes read cache utilization resulting in faster access to critical data. This invention utilizes complex profiling processes to accurately predict if data presently in a read cache memory is likely to be read in the near future. If it is, the data is maintained in the read cache. If it is not, the processes replace the data least likely to be read with data in the storage devices that is most likely to be read. The result is a very efficient utilization of the cache for improved performance.
Dot Hill Systems Corp. designs, manufactures, and markets a range of software and hardware storage systems for the entry and mid-range storage markets worldwide. Its storage solutions comprise of integrated hardware, firmware, and software products employing a modular system that allows end-users to add various protocol, performance, capacity, or data protection schemes. The company offers enterprise storage solutions and virtual redundant array of independent disks (RAID) adapters for the entry and midrange storage markets.
Finally, Francesca’s Holdings Corp(NASDAQ:FRAN), gained 1.06%, to $12.35.
Francesca’s Holdings Corporation (FRAN) stated financial results for the second quarter ended August 1, 2015.
SECOND QUARTER RESULTS
Net sales raised 9% to $106.0 million from $97.3 million in the comparable preceding year period. This enhance was driven by 82 new boutiques opened since the comparable preceding year quarter. We opened 19 boutiques during the quarter bringing the total boutique count to 608 at the end of the second quarter.
Comparable sales reduced 4% due to lower comparable transactions. DTC sales were flat at $3.6 million in each of the thirteen weeks ended August 1, 2015 and August 2, 2014.
Gross profit, as a percentage of net sales, raised to 47.4% from 46.6% in the preceding year quarter. This enhance is driven by 260 basis points improvement in merchandise margin partially offset by 170 basis points deleveraging of occupancy costs. The merchandise margin improvement is attributable to the reduced amount of charges related to the disposal of slow-moving merchandise in addition to lower promotions contrast to last year.
Francesca’s Holdings Corporation, through its auxiliaries, operates a chain of retail boutiques. It offers fashion apparel, jewelry, accessories, and gifts primarily for women between the ages of 18 and 35.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
